Accessibility Statement
This statement applies to content published on the funding.re.ukri.org domain.
This website is run by UK Research and Innovation (UKRI). It is designed to be used by as many people as possible. The text should be clear and simple to understand. You should be able to:
- Zoom in up to 300% without problems
- Navigate most of the website using just a keyboard
- Navigate most of the website using speech recognition software
- Use most of the website using a screen reader (including the most recent versions of JAWS, NVDA and VoiceOver)
How accessible this website is
This website meets all WCAG 2.1 AA guidelines.
Feedback and contact information
If you need information from this service in a different format such as accessible PDF, large print, easy read, audio recording or braille:
- Email: data_queries@re.ukri.org
In your message, include:
- The web address (URL) of the content
- Your email address and name
- The format you need, for example plain text, braille, BSL, large print or audio CD
Reporting accessibility problems with this website
Reporting accessibility problems with this website. If you find any problems that are not listed on this page or you think we're not meeting the accessibility requirements, contact us data_queries@re.ukri.org
Enforcement procedure
If you contact us with a complaint and you're not happy with our response contact the contact the Equality Advisory and Support Service (EASS) .
The Equality and Human Rights Commission (EHRC) is responsible for enforcing the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018 (the 'accessibility regulations').
Technical information about this website's accessibility
UKRI is committed to making its websites accessible, in accordance with the Public Sector Bodies (Websites and Mobile Applications) (No. 2) Accessibility Regulations 2018.
Compliance status
This website is compliant with the Web Content Accessibility Guidelines version 2.1 AA standard.
Preparation of this accessibility statement
This statement was prepared on 22 September 2023. We will keep this statement under regular review.